Patient recruitment is a critical yet challenging phase in clinical trials. EMIS has been lauded for its significant contribution to this area with the Innovation award in the 2024 Pharmaceutical Technology Excellence Awards for developing Recruit, a tool designed to streamline the patient recruitment process.
The Pharmaceutical Technology Excellence Awards celebrate the greatest achievements and innovations in the pharmaceutical industry. Powered by GlobalData’s business intelligence, the Awards recognize the people and companies that are driving change in the industry.
Go deeper with GlobalData
The Recruit tool has revolutionized the clinical trial recruitment process enabling primary care professionals to easily identify and connect with patients eligible to take part in clinical trials.
Streamlining patient recruitment in clinical trials
Recruit addresses the persistent issue of recruitment, which has historically been a bottleneck for clinical trials. According to industry research, 80%1 of trials face delays due to recruitment challenges, and 30%2 of the overall trial cost is spent on this phase. EMIS’s solution makes it simple for general practitioners (GPs) to invite patients, thus enhancing access to trials to a broader patient base.
By embedding Recruit within the existing GP clinical system, EMIS Web, EMIS has ensured that the tool is a natural extension of the daily workflow, making it as effortless as possible for GPs to identify and engage with potential trial candidates. This integration has proven to be a critical factor in the tool’s success, as it leverages the trusted relationship between GPs and patients to facilitate recruitment.
Embedded in primary care: A strategic approach
Embedding Recruit within primary care clinical software has been a cornerstone of EMIS’s award-winning approach. This has not only simplified the process for GPs but has also significantly enhanced patient access to clinical trials.
Recruit has streamlined the recruitment process, reducing the administrative burden on healthcare professionals. The tool surfaces potential candidates directly within the GP’s dashboard, allowing for quick engagement and consent acquisition. The design is a testament to EMIS’s understanding of the primary care landscape and its commitment to creating solutions that work seamlessly within it.
Furthermore, the success of Recruit is driven by its exceptional user experience for GPs. Feedback from healthcare professionals indicates that the tool’s integration into their daily practice has made it easier to support clinical research.
The success of Recruit is reflected in its tangible outcomes for sponsors and trial delivery organizations. The tool has supported 11 trials, inviting over 500,000 patients to participate, and has been activated by over 1,000 GP practices covering over 11 million patients. The level of engagement demonstrates Recruit’s capability to connect pharmaceutical organizations with healthcare providers for effective trial recruitment.
Scalability and adaptability: Key features of Recruit
Recruit’s scalability and adaptability are key features that have contributed to its award-winning status. The tool’s design allows for rapid set-up, adjustable cohorts, and scalable engagement programs to match the screening capacity of each trial. This flexibility ensures that the recruitment process is optimized for the specific needs of each study, allowing for a more targeted approach to patient recruitment.
The ability to scale and adjust the recruitment process is crucial in the dynamic environment of clinical trials. Recruit’s innovative design enables pharmaceutical organizations to match the number of invitations sent to patients with the capacity of trial sites, ensuring an optimized flow of participants. This level of control and adaptability is a significant advancement in the recruitment process, addressing one of the industry’s most pressing challenges.
EMIS’s Recruit as a potential change agent in clinical research
EMIS’s Recruit tool has demonstrated the potential to be a significant change agent in the pharmaceutical industry. By innovatively addressing the challenges of clinical trial recruitment, EMIS has set a new benchmark for efficiency and effectiveness in this critical area. The company’s dedication to improving clinical safety and patient outcomes is evident in the thoughtful design and successful implementation of Recruit. As EMIS continues to drive research and innovation, its contributions to the industry are recognized with this well-deserved award.
“Winning this award for Innovation is a testament to the groundbreaking impact of our Recruit solution. By empowering GP practices to effortlessly connect patients with clinical trials, we’ve accelerated research and expanded access to diverse populations. This recognition highlights our commitment to the NHS in transforming healthcare through cutting-edge technology, enhancing patient engagement and supporting the UK as a leading destination for global clinical research.” – John McCormack, Chief Revenue Officer, EMIS
Company Profile
EMIS is the UK’s leading integrated healthcare technology provider. Patient care is at the heart of everything we do: our goal is to be the leading provider of innovative healthcare technology that improves people’s lives.
EMIS systems are at the fingertips of more than 100,000 NHS clinicians. With the #1 or #2 market positions in all major healthcare settings in the UK, our systems have a far-reaching impact. No matter the setting our goal is the same: to help our customers provide the best possible patient care.
We’re committed to playing our part in vital long-term progress and development of healthcare for the UK population, working with the life sciences industry.
Double award-winning Recruit is a new software innovation that helps GPs match eligible patients to clinical trials. Under-recruitment of patients into clinical trials is a huge problem – it can lead to delays in translating new science discoveries into medical practice, which can slow down patients receiving new treatment breakthroughs. Together with the life sciences industry we’re accelerating that process so that everyone benefits.
EMIS was set up by two practicing Yorkshire GPs with a focus on using technology to improve the care they provided directly to their patients. More than 35 years later EMIS remains clinically-led. Our large team of practicing clinicians guide the development of clinical systems that meet the needs of NHS clinicians: including GPs, nurses and high street pharmacists.
In every way we can, we’re supporting the UK’s front-line clinicians to improve the health of the UK, one patient at a time.
Contact Details
EMIS Head Office,
Fulford Grange,
Micklefield Lane,
Rawdon,
Leeds,
LS19 6BA
Phone: 0330 024 1269
Links
Website: emishealth.com
References:
1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342339/
2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342338
© EMIS Group Limited. All Rights Reserved
